Gene Biotherapeutics, Inc. CRXM
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Christopher J. Jemapete | United States | 4000000 | 0 | 4000000 | 0 | 4000000 | 8.1 % | 28/04/2021 |
| Christopher J. Jemapete | OR PLACE OF ORGANIZATION | 4000000 | 0 | 4000000 | 10 | 4000000 | 27.6 % | 18/03/2021 |
| Christopher J. Jemapete | OR PLACE OF ORGANIZATION | 3500000 | 0 | 3500000 | 10 | 3500000 | 24.2 % | 01/03/2021 |
| Christian F. Coluccio | United States | 200000 | 525000 | 200000 | 525000 | 725000 | 5 % | 22/12/2020 |
| NOSTRUM PHARMACEUTICALS, LLC | DELAWARE | 150442478 | 0 | 150442478 | 0 | 150442478 | 91.2 % | 01/06/2020 |
| Nirmal Mulye, Ph.D.* | States of America | 150442478 | 0 | 150442478 | 0 | 150442478 | 91.2 % | 01/06/2020 |
| Hal Mintz | United States of America | 0 | 10193299 | 0 | 10 | 10193299 | 8.52 % | 19/09/2012 |
| Sabby Healthcare Volatility Master Fund, Ltd. | Cayman Islands | 0 | 10193299 | 0 | 10 | 10193299 | 8.52 % | 19/09/2012 |
| Sabby Management, LLC | Delaware | 0 | 10193299 | 0 | 10 | 10193299 | 8.52 % | 19/09/2012 |
| Hal Mintz | United States of America | 0 | 10304401 | 0 | 10 | 10304401 | 8.61 % | 30/08/2012 |
| Sabby Management, LLC | Delaware | 0 | 10304401 | 0 | 10 | 10304401 | 8.61 % | 30/08/2012 |
| Sabby Healthcare Volatility Master Fund, Ltd. | Cayman Islands | 0 | 10304401 | 0 | 10 | 10304401 | 8.61 % | 30/08/2012 |
| Sabby Management, LLC | Cayman Islands | 0 | 8928571 | 0 | 8928571 | 8928571 | 7.5 % | 16/02/2012 |
| Hal Mintz | Cayman Islands | 0 | 8928571 | 0 | 8928571 | 8928571 | 7.5 % | 16/02/2012 |
| Sabby Healthcare Volatility Master Fund, Ltd. | Cayman Islands | 0 | 8928571 | 0 | 8928571 | 8928571 | 7.5 % | 16/02/2012 |